1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Veterinary Therapeutics Market -, Vaccines, Nutritional Feed Additives, and Disinfectants; Animal Type - Companion Animals and Livestock Animals - Kingdom of Saudi Arabia Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Veterinary Therapeutics Sector in Kingdom of Saudi Arabia, Forecast until 2025

  • June 2017
  • 95 pages
  • ID: 5027970
In this report:
Based on product type, the KSA veterinary therapeutics market has been segmented into pharmaceuticals (ectoparasiticides, endoparasiticides, antibiotics, anti-inflammatories, and endectocides), vaccines (bacterial vaccines, and viral vaccines), nutritional feed additives (amino acids, vitamins, and minerals), and disinfectants (floor disinfectants, and disinfectants used in tissues).

Summary

Table of Contents

Kingdom of Saudi Arabia Veterinary Therapeutics Market: Summary

This industry report on the KSA veterinary therapeutics market examines the current and future prospects of the market. The industry report comprises a detailed executive summary, containing a market snapshot that offers global information of different segments and subsegments.

The industry research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts together with info collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and several worldwide and national databases. The study offers market value in terms of US$ Mn for each section for the time span from 2015 to 2025, examining the macro and micro environmental factors. Growth rates for each division within the KSA veterinary therapeutics market have been determined after a thorough analysis of past trends, demographics, next trends, technological developments, and regulatory requirements.

Kingdom of Saudi Arabia Veterinary Therapeutics Market: Drivers and Restraints

A in-depth qualitative analysis of factors responsible for driving and restraining market increase and future opportunities has been specified in the market survey part. This section of the report also comprises Analysis of market appeal that offers a thorough analysis of the global ambitious scenario in the KSA veterinary therapeutics market.

Market income in terms of US$ Mn for the time between 2015 and 2025 along with the CAGR from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved exhaustive study of product features of various types. On top of, market related factors including growing preference for technologically advanced services, product innovation, and increasing number of acute and chronic animal and zoonotic diseases in different geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Kingdom of Saudi Arabia Veterinary Therapeutics Market: Segments

Established on product variety, the KSA veterinary therapeutics market has been divided into pharmaceuticals (ectoparasiticides, endoparasiticides, antibiotics, anti-inflammatories, and endectocides), vaccines (bacterial vaccines, and viral vaccines), nutritional feed additives (amino acids, vitamins, and minerals), and disinfectants (floor disinfectants, and disinfectants used in tissues). The sector has been further studied from the point of view of main animal types. Established on animal type, the industry has been classified into companion animals and livestock animals.

This study offers detailed analysis of the veterinary therapeutics market. The stakeholders for this analysis contain pharmaceutical companies providing veterinary medicines. For providing a snapshot of this market to the stakeholders, executive summary section is included in this market report, which summarizes the market value, forecasts and competition for distinct product type and animal type. Market share review among the key market players is analyzed to signify percentage share of the main players operating in the KSA veterinary therapeutics market. Moreover, the analysis incorporates Analysis of market appeal by product class and animal type that depicts the most engaging and meaningful segments in the KSA market in 2016.

Top competitors specified in this report

The study also includes list main overall players in the sector, their SWOT analysis, market share of these players in the veterinary therapeutics market, main business strategies, product portfolios, and recent evolutions. Key market players decribed in this industry report contain, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Incorporated, Ceva Sante Animale, Dechra Animal Health, Elanco Animal Health, Merck Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis, Inc

The KSA veterinary therapeutics segment has been split as follows:

KSA Veterinary Therapeutics Market, by Product Type

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Nicolas helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H2 2018

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H2 2018

  • $ 3500
  • November 2018

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H2 2018SummaryT Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) pipeline Target constitutes ...

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Pipeline Review, H2 2018

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Pipeline Review, H2 2018

  • $ 3500
  • November 2018

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Pipeline Review, H2 2018SummarySerine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) pipeline Target ...

Radiodermatitis - Pipeline Review, H2 2018

Radiodermatitis - Pipeline Review, H2 2018

  • $ 2000
  • November 2018

Radiodermatitis - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Radiodermatitis - Pipeline Review, H2 2018, provides an overview of ...


ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on